Tianfei Yu, Jinyong Xia, Haichang Yin, Nana Yi, Lanlan Zhang, Ming Li
{"title":"Enhancing the robustness of Mendelian randomization studies: lessons from a two-sample analysis of viral infections and colorectal cancer.","authors":"Tianfei Yu, Jinyong Xia, Haichang Yin, Nana Yi, Lanlan Zhang, Ming Li","doi":"10.1186/s13027-024-00626-y","DOIUrl":null,"url":null,"abstract":"<p><p>This Matters Arising article critically examines the study \"Genetic susceptibility association between viral infection and colorectal cancer risk: a two-sample Mendelian randomization analysis\" by Li et al., highlighting both its contributions and methodological limitations. Their study employed two-sample Mendelian randomization (MR) to explore potential causal links between viral infections and colorectal cancer (CRC), identifying significant associations with infections such as herpes simplex virus and measles. However, several aspects of the methodology warrant scrutiny, including the relaxation of instrumental variable selection thresholds, the handling of potential pleiotropy, and the interpretation of biologically implausible findings. While leveraging advanced MR techniques such as MR-RAPS, cML, ConMix, and dIVW to address challenges like pleiotropy and weak instruments, the study encountered issues related to heterogeneity, insufficient exploration of biological plausibility, and a lack of detailed reporting on instrumental variable (IV) selection and preprocessing. This Matters Arising calls for more rigorous sensitivity analyses, improved transparency in IV selection criteria and harmonization of genome-wide association study (GWAS) datasets, particularly in addressing differences between self-reported and clinically diagnosed infections. Additionally, the Matters Arising article calls for a deeper exploration of biological mechanisms, such as the role of immune modulation and inflammation, to better interpret the observed associations. By addressing these limitations, future MR studies can enhance methodological rigor, improve reproducibility, and provide more robust insights into the causal pathways linking viral infections to CRC risk.</p>","PeriodicalId":13568,"journal":{"name":"Infectious Agents and Cancer","volume":"19 1","pages":"60"},"PeriodicalIF":3.1000,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11619104/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Agents and Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13027-024-00626-y","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
This Matters Arising article critically examines the study "Genetic susceptibility association between viral infection and colorectal cancer risk: a two-sample Mendelian randomization analysis" by Li et al., highlighting both its contributions and methodological limitations. Their study employed two-sample Mendelian randomization (MR) to explore potential causal links between viral infections and colorectal cancer (CRC), identifying significant associations with infections such as herpes simplex virus and measles. However, several aspects of the methodology warrant scrutiny, including the relaxation of instrumental variable selection thresholds, the handling of potential pleiotropy, and the interpretation of biologically implausible findings. While leveraging advanced MR techniques such as MR-RAPS, cML, ConMix, and dIVW to address challenges like pleiotropy and weak instruments, the study encountered issues related to heterogeneity, insufficient exploration of biological plausibility, and a lack of detailed reporting on instrumental variable (IV) selection and preprocessing. This Matters Arising calls for more rigorous sensitivity analyses, improved transparency in IV selection criteria and harmonization of genome-wide association study (GWAS) datasets, particularly in addressing differences between self-reported and clinically diagnosed infections. Additionally, the Matters Arising article calls for a deeper exploration of biological mechanisms, such as the role of immune modulation and inflammation, to better interpret the observed associations. By addressing these limitations, future MR studies can enhance methodological rigor, improve reproducibility, and provide more robust insights into the causal pathways linking viral infections to CRC risk.
期刊介绍:
Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer.
The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular:
• HPV and anogenital cancers, as well as head and neck cancers;
• EBV and Burkitt lymphoma;
• HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases;
• HHV8 and Kaposi sarcoma;
• HTLV and leukemia;
• Cancers in Low- and Middle-income countries.
The link between infection and cancer has become well established over the past 50 years, and infection-associated cancer contribute up to 16% of cancers in developed countries and 33% in less developed countries.
Preventive vaccines have been developed for only two cancer-causing viruses, highlighting both the opportunity to prevent infection-associated cancers by vaccination and the gaps that remain before vaccines can be developed for other cancer-causing agents. These gaps are due to incomplete understanding of the basic biology, natural history, epidemiology of many of the pathogens that cause cancer, the mechanisms they exploit to cause cancer, and how to interrupt progression to cancer in human populations. Early diagnosis or identification of lesions at high risk of progression represent the current most critical research area of the field supported by recent advances in genomics and proteomics technologies.